MedLumics
PrivateLast Round
VC Round
Jul 29, 2024
Total Funding Raised
$66.11M
Company Overview
MedLumics is a medical device company developing AblaView, an optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MedLumics Comparables
Compare MedLumics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CardioFocus | 85% | |
| Kardium | 80% | |
| Adagio Medical | 80% |
MedLumics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 29, 2024 | ||||
| VC Round | Feb 13, 2024 | ||||
| Series E | Feb 10, 2021 | ||||
| Grant | May 1, 2019 | ||||
| Series B | Mar 20, 2017 | ||||
Series A | Dec 1, 2011 |
MedLumics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Asabys Partners | VC Round, Series E |
| CDTI Innvierte | Series E |
| Seroba Life Sciences | Series B |
| Andera Partners | Series E, Series B |
| European Commission | Grant |
| Ysios Capital | Series B, Series A |
| Innogest Capital | Series B, Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 10, 2021
$22M round led by Asabys Partners and VI Partners.
- May 1, 2019
$2.76M grant from the European Commission
MedLumics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about MedLumics's valuation, stock price, and market status.
Is Medlumics a public or private company?
Medlumics is a private company.
What is the current stock price of Medlumics?
Medlumics is a private company with no public stock price. No recent secondary market data is available.
How much is Medlumics worth (valuation)?
Valuation information for Medlumics is not publicly available.
Can I buy Medlumics stock?
Medlumics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Medlumics's last funding round?
Medlumics's most recent funding round was VC Round on February 13, 2024.
Who are the main investors in Medlumics?
Key investors in Medlumics include Asabys Partners, Ysios Capital, VI Partners, Caixa Capital Risc.
Will Medlumics IPO soon?
No public IPO plans have been announced for Medlumics.
How can I track Medlumics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Medlumics's secondary market activity and sign up for updates.